CLECELL: A New Bioprinted Model Could Aid COVID-19 Vaccine Testing

April 23, 2020 / by Vanesa Listek / 3D Printing / Bioprinting

We present one of our successful projects of april: an artificial respiratory tract epithelium manufactured by our private label 3D bioprinter, U-FAB. Our model could serve as a solution to the ongoing SARS-Cov-2 pandemic as an alternative in vitro testing bed; we already received contact from Harvard’s school of medicine. We hope to make more advances to provide significant breakthroughs not only for the ongoing pandemic, but also for R&D regarding all existing viruses as a whole.

For more information:

See also, an equivalent for our korean customers:


Head Office

H6107 Healthcare Innovation Park, 172 Dolma-ro,

Seongnam-si, Gyeonggi-do, Korea

R&D Center

C-1506, 26, Beobwon-ro 9-gil, Songpa-gu, Seoul, Korea

Phone : +82 2-6951-3100      E-mail :

  • Facebook
  • Twitter
  • YouTube
  • Instagram